Pharmacogenomics in Practice: Cardiology

TARGET AUDIENCE

This course is designed for all healthcare professionals, including Nurses, Nurse Practitioners, Pharmacists, Physicians and Physician Assistants.

---

LEARNING MODULES

1. Precision medicine and PGx (2 units)
2. Foundations of PGx (3 units)
3. All about testing (3 units)
4. Principles of PGx decision making (5 units) 
5. Integrating PGx into your cardiology practice (3 units)
   

---

LEARNING OBJECTIVES

Upon completion of this activity, participants should be able to:

Review foundational genomic concepts and nomenclature. Describe how PGx variation affects the pharmacokinetics and pharmacodynamics of cardiovascular medications. Order quality PGx testing when appropriate for cardiology patients across their patient care journey. Explain the individual and societal risks and benefits of genetic testing in the healthcare setting. Identify gene-drug pairs and seminal clinical trial data with a high level of evidence in cardiology. Develop a stepwise decision-making process for the integration of PGx with clinical variables (e.g. phenoconversion) that known to impact PK/PD to make appropriate recommendations for cariology patients and populations. Identify one's own role and that of other interprofessional team members to apply PGx into practice.

COURSE DURATION

Once enrolled, learners have 60 days to complete the program.

PLANNING COMMITTEE

Philip Empey, PharmD, PhD,  FCCP Associate Professor, Pharmacy and Therapeutics, Associate Director, Institute of Precision Medicine; University of Pittsburgh School of Pharmacy

---

PLANNING COMMITTEE

	James Coons, PharmD, FCCP, FACC, BCCP Professor, Pharmacy and Therapeutics, PGY2 Cardiology Residency Program Director, University of Pittsburgh School of Pharmacy
	Lucas Berenbrok, PharmD, MS, BCACP, TTS Associate Professor, Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy
	Deepak Voora, MD  Executive Director, VA National Pharmacogenomics Program VA Central Office, Washington, DC
	Jill Bates PharmD, MS, BCOP, DipACLM, FASHP Deputy Executive Director, VA National Pharmacogenomics Program VA Central Office, Washington, DC
	Trina Walker, DNP, APRN, FNP-C Assistant Professor, Nursing Creighton University
	Nguyen Park, MS, PA-C President and Founder, Society of PAs in Genetics/Genomics

---

PRENSENTERS (ALPHABETICAL ORDER)

	Lucas Berenbrok, PharmD, MS, BCACP, TTS Associate Professor, Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy
	Kelly Caudle, PharmD, PhD, BCPS, FCCP Associate Member, St. Jude Children's Research Hospital CPIC Director
	James Coons, PharmD, FCCP, FACC, BCCP Professor, Pharmacy and Therapeutics, PGY2 Cardiology Residency Program Director, University of Pittsburgh School of Pharmacy
	Philip Empey, PharmD, PhD,  FCCP Associate Professor, Pharmacy and Therapeutics, Associate Director, Institute of Precision Medicine; University of Pittsburgh School of Pharmacy
	Mylynda Massart, MD, PhD Associate Professor, Department of Family Medicine Primary Care Precision Medicine University of Pittsburgh
	Lisa Parker, PhD Director, Center for Bioethics and Health Law University of Pittsburgh
	Robert Schuck, PharmD, PhD Deputy Director, Division of Translational and Precision Medicine Office of Clinical Pharmacology Center for Drug Evaluation and Research US Food and Drug Administration
	Michelle Whirl-Carrillo, PhD Principal Investigator and Director, PharmGKB Department of Biomedical Data Science Stanford University

---

CONFLICT OF INTEREST

Dr. Coons discloses that he receives grant/research support from Heart Rhythm Society, and Pfizer-Bristol Myers Squibb Alliance. He is a consultant for Merck and Pfizer-Bristol Myers Squibb Alliance.

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

ACCREDITATION

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Pharmacy (CPE)

This knowledge-based activity provides 5.0 contact hours of continuing pharmacy education credit.

Physician (CME)

The University of Pittsburgh designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing (CNE)

The maximum number of hours awarded for this Continuing Nursing Education activity is 5.0 contact hours.

Physician Assistant (AAPA)

The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.  

Other healthcare professionals

Will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

---

DISCLAIMER STATEMENT

The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

---

HOW TO OBTAIN CONTINUING EDUCATION

Continuing education can be claimed for the above learner groups. Learners must complete the full program (all modules, attain grades of 80% or higher on assessments, and participate in the live session) as well as submit the required information to the CE office (e.g. profile information and evaluations) prior to the deadline to receive continuing education credit. Partial credit will not be awarded.

Released: 8/13/2024
Expires: 08/12/2027